Search Results - Cameron, David
- Showing 1 - 3 results of 3
-
1
-
2
Nottingham Prognostic Index Plus: validation of a clinical decision making tool in breast cancer in an independent series by Green, Andrew R., Soria, Daniele, Stephen, Jacquelin, Powe, Desmond G., Nolan, Christopher C., Kunkler, Ian, Thomas, Jeremy, Kerr, Gillian R., Jack, Wilma, Cameron, David, Piper, Tammy, Ball, Graham R., Garibaldi, Jonathan M., Rakha, Emad, Bartlett, John M.S., Ellis, Ian O.
Published 2016Get full text
-
3
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial by Cameron, David, Brown, Julia, Dent, Rebecca, Jackisch, Christian, Mackey, John, Pivot, Xavier, Steger, Guenther, Suter, Thomas, Toi, Masakazu, Parmar, Mahesh, Laeufle, Rita, Im, Young-Hyuck, Romieu, Gilles, Harvey, Vernon, Lipatov, Oleg, Pienkowski, Tadeusz, Cottu, Paul, Chan, Arlene, Im, Seock-Ah, Hall, Peter, Bubuteishvili-Pacaud, Lida, Henschel, Volkmar, Deurlog, Regula, Pallaud, Celine, Bell, Richard
Published 2013Get full text